Ascentage Pharma

Ascentage Pharma is a biopharmaceutical company

Ascentage Pharma is a China-based, global-oriented, clinical-stage biopharmaceutical company, dedicated to discovery and development of the “first-in-class” and the “best-in-class” targeted small-molecule cancer therapeutics. A rich portfolio of innovative small-molecule agents has been discovered and developed through the company’s unique, robust, and world-class innovative drug development pipeline. Currently, Ascentage Pharma has three molecules in phase I-II trials in US, Australia and China, and another four molecules at IND reviewing or IND-enabling stages.